Search
for

    Learn

    5 / 801 results

      learn Osteopontin

      signaling protein that, when suppressed, may grow hair by reducing inflammation and stem cell loss

      learn SCUBE3

      a signaling molecule from dermal papilla cells being actively researched

      learn Exosomes

      Microscopic delivery system that sends growth-promoting signals to hair follicles

    Research

    5 / 1000+ results

    Community Join

    5 / 1000+ results

      community One year on finasteride has reversed some aging

      in Chat  198 upvotes 8 months ago
      Finasteride and minoxidil use resulted in a more youthful appearance and improved skin. There is debate about their effects on collagen and skin aging, with no solid evidence supporting significant changes due to finasteride.

      community JXL082 is not PP405 and Everychem followed the wrong lead

      in Research/Science  43 upvotes 10 months ago
      JXL082 is not the same as PP405, leading to a halt in sales and a plan to synthesize the real PP405. There is skepticism about the safety and effectiveness of JXL082 and PP405, with concerns about patent issues and the long-term impact on hair growth.

      community 35M, been on Finasteride for 12 years, oral min 5mg 2 years no HT

      in Update  1181 upvotes 1 month ago
      A 35-year-old man has used finasteride for 12 years and oral minoxidil at 5 mg for 2 years, achieving significant hair regrowth and density without side effects, avoiding a hair transplant. He recommends consistency with medication and highlights the effectiveness and affordability of oral minoxidil.

      community The Real Reason For Hair Loss?

      in Research/Science 5 months ago
      Hair loss is linked to scalp fibrosis and tension, which result from chronic mechanical stress and androgenic signaling. Treatments include blocking androgens with finasteride, promoting hair growth with topical minoxidil, and improving scalp mobility through exercises.

      community Quote from Pelage (PP-405) Spokesperson...

      in Research/Science  122 upvotes 7 months ago
      Pelage is developing a topical hair follicle stem cell therapy, PP405, for non-scarring alopecias like androgenetic alopecia, with Phase III trials planned and a potential market launch by 2027. The treatment may not require continuous use after initial regrowth.